Ai Xiaojuan, Wu Cuiling, Yin Tingting, Zhur Olena, Liu Congling, Yan Xiaotao, Yi CuiPing, Liu Dan, Xiao Linhu, Li Wenkai, Xie Binbin, He Hailun
School of Life Sciences, Central South University, Changsha, China.
Department of Biochemistry, Changzhi Medical College, Changzhi, China.
Front Microbiol. 2021 Jun 24;12:682290. doi: 10.3389/fmicb.2021.682290. eCollection 2021.
Rice bran is an industrial byproduct that exerts several bioactivities despite its limited bioavailability. In this study, rice bran fermented with MF423 (FLRB) had enhanced antidiabetic effects both and . FLRB could increase glucose consumption and decrease lipid accumulation in insulin resistant HepG2 cells. Eight weeks of FLRB treatment significantly reduced the levels of blood glucose and lipids and elevated antioxidant activity in type 2 diabetic mellitus (T2DM) mice. H&E staining revealed alleviation of overt lesions in the livers of FLRB-treated mice. Moreover, high-throughput sequencing showed notable variation in the composition of gut microbiota in FLRB-treated mice, especially for short-chain fatty acids (SCFAs)-producing bacteria such as and . In conclusion, our results suggested that rice bran fermentation products can modulate the intestinal microbiota and improve T2DM-related biochemical abnormalities, so they can be applied as potential probiotics or dietary supplements.
米糠是一种工业副产品,尽管其生物利用度有限,但具有多种生物活性。在本研究中,用MF423发酵的米糠(FLRB)在体内和体外均具有增强的抗糖尿病作用。FLRB可增加胰岛素抵抗的HepG2细胞中的葡萄糖消耗并减少脂质积累。八周的FLRB治疗显著降低了2型糖尿病(T2DM)小鼠的血糖和血脂水平,并提高了抗氧化活性。苏木精-伊红染色显示FLRB治疗小鼠肝脏中的明显病变有所减轻。此外,高通量测序显示FLRB治疗小鼠的肠道微生物群组成有显著变化,尤其是对于产生短链脂肪酸(SCFA)的细菌,如[具体细菌名称1]和[具体细菌名称2]。总之,我们的结果表明,米糠发酵产品可以调节肠道微生物群并改善与T2DM相关的生化异常,因此它们可作为潜在的益生菌或膳食补充剂应用。